Abstract: This invention relates to devices and methods for safely reconstituting and administering topical therapeutic or cosmetic compositions. The topical applicator according to the invention is particularly well suited for storing, reconstituting, and administering or applying highly toxic substances.

Abstract: The invention relates to a transdermal therapeutic system (TTS), which is suited for the administration of a peptide to a patient through skin treated with ablation. The transdermal therapeutic system includes a back layer and an active substance-containing layer that contains at least one peptide and a carrier substance, preferably as a textile web material.

Abstract: A conformable barrier sheet comprising a polymeric film having a tensile elongation at least 2 fold greater than a polyethylene terephthalate film of equal dimensions and under an equal load; a planarization layer; and a plasma-deposited amorphous glass layer comprising silicon, carbon, and hydrogen; wherein the planarization layer is disposed on the polymeric film, the amorphous glass layer is deposited on the planarization layer, and wherein the barrier sheet is sufficiently conformable that after undergoing a tensile elongation within the range of more than 2% to 20%, the barrier sheet has a moisture vapor transmission rate essentially unchanged compared with prior to being elongated, a method of making the conformable barrier sheet, a transdermal device comprising the conformable barrier sheet, a method of delivering a drug to a mammal using the device, and a method of protecting an article using the conformable barrier sheet are provided.

Abstract: An apparatus and method for applying a beneficial agent to the skin is disclosed in one embodiment of the invention as including first and second chemical reactants, each being compatible with the skin. The first and second chemical reactants react with one another to generate a beneficial agent and enhance the permeability of the skin (e.g., by generating heat). The beneficial agent may then be applied to the skin while the permeability of the skin is enhanced. In selected embodiments, the first chemical reactant includes one or more metals, or alloys thereof, that are compatible (i.e., not harmful) with the skin. Similarly, in selected embodiments, the second chemical reactant may include water. In certain embodiments, the beneficial agent generated by the first and second chemical reactants includes an antioxidant such as hydrogen.

Abstract: An apparatus, system, and method for storing liquid from a tissue site are presented. The apparatus includes a delivery tube that may have at least one lumen. The delivery tube may be operable to transmit reduced pressure to the tissue site and to receive liquid from the tissue site. The apparatus may also include an absorbent material disposed in the at least one lumen. The absorbent material may be operable to absorb the liquid from the tissue site. The delivery tube may be formed with a number of recesses.

Abstract: A therapeutic device includes an elastomeric outer shell configured as a human hand and defining an interior area, the outer shell having a finger end opposite a wrist end. The device includes a pocket in the interior area, the pocket being defined by an inner wall. An endplate is coupled to the outer shell and coupled to the inner wall to define a closed area between the outer shell and pocket, the endplate having an opening for allowing access to the pocket. A fill material is positioned in the closed area. The device includes a vibrating unit removably positioned in the pocket through the endplate opening, the vibrating unit having a lock complementary to a catch to couple the vibrating unit to the endplate, the vibrating unit having a vibrating motor in electrical communication with a power source and a switch.

Abstract: The present invention relates to compositions including a homeopathic aqueous substance active (HASA) and at least one hydrophilic gelling agent, the HASA comprises a homeopathic compound at a potency of 30 C or higher and an uninhibited aqueous composition. The present invention also relates to methods of preparing a hydrophilic HASA-gel matrix. The method includes combining a homeopathic compound and an uninhibited aqueous composition to produce a HASA; combining the HASA with at least one hydrophilic gelling agent; and thereafter, forming the hydrophilic HASA-gel matrix by use of at least one of a thickening agent, a crosslinking agent, or a polymerization agent.

Abstract: This invention relates to an implement 1 for applying a volume of liquid to a treatment surface. The implement includes a support means 3 onto which is mounted a receptacle 2, the receptacle defining a reservoir space 4 which receives the liquid. The receptacle includes a wall 6 having a working surface that is used to spread the liquid over the treatment surface. The wall 6 is resiliently deformable so in use the working surface maintains contact with the treatment surface when spreading the liquid. The implement has a specific application in applying a transdermal lotion to the axilla area of the user. The invention also relates to a system for transdermal administration of a physiological active agent from a liquid composition and a method of conducting the same.

Abstract: The present invention relates generally to the field of hemodialysis, including methods and kits that can be employed to improve hemodialysis therapy. The present invention encompasses methods and kits useful for reducing vascular access complications associated with hemodialysis therapy and prolonging the period of time for which a vascular access site can be used in a patient.

Abstract: Ocular inserts including a cylindrical body, a lumen and a hydrophilic polymer and strips thereof are suitable for contact with an eye of a subject suffering from an eye disorder. While in contact with an eye, the ocular inserts may be used for releasing various agents, including pharmaceutically active agents, and effecting a treatment of one or more eye disorders.

Abstract: An improved Transdermal Delivery System (TDS) comprising a backing layer inert to the components of the matrix, a self-adhesive matrix containing rotigotine and a protective foil or sheet to be removed prior to use, characterized in that the self-adhesive matrix consists of a solid or semi-solid semi-permeable polymer (1) wherein rotigotine in its free base form has been incorporated, (2) which is saturated with rotigotine and contains said rotigotine as a multitude of microreservoirs within the matrix, (3) which is highly permeable for the free base of rotigotine, (4) which is impermeable for the protonated form of rotigotine, (5) wherein the maximum diameter of the microreservoirs is less than the thickness of the matrix. is provided. Said TDS provides for enhanced flux of rotigotine across the TDS/skin interface.

Abstract: A transdermal drug delivery device is disclosed. Over an extended wear period, the device causes cumulative moderate irritation plus significant irritation of less than 5% and/or achieves a meaningful degree of detachment over a seven day period of less than 20%.

Abstract: A surgical tissue therapy device includes a sealant layer and a collection chamber. The sealant layer functions so as to create a sealed enclosure or space between it and the surface of a patient by forming, preferably, an airtight seal around a surgical area of skin trauma. The closed incision tissue therapy device also comprises a collection chamber, which may comprise an elongate tubular chamber with a plurality of longitudinally spaced openings. The collection chamber may be configured to be in fluid communication with the sealant layer and the area of skin trauma and functions as to distribute the negative pressure applied to a surgically closed area of skin trauma. Preferably, the pressure under the sealant layer is reduced by expanding the volume of the enclosure space and thereby decreasing the density of air molecules under the sealant layer.

Abstract: A method for irrigation of a wound, wherein the method involves the use of a reservoir housing containing a wound irrigation solution and a discharge means attached thereto, wherein the discharge means has multiple ports for directing a stream of the solution at a wound at an appropriate pressure.

Abstract: A therapeutic device and method for blocking pain in a patient's digit includes a ring-like vibratory element adapted to be fitted about the digit temporarily and controller coupled to the ring-like vibratory element for controlling its operation. By applying vibration to the patient's digit, pain transmission is blocked or lessened along the digit, allowing the patient or a caregiver to provide treatment to the digit with reduced pain, such as when a diabetic's finger is to be stuck for drawing blood for a blood sugar measurement). Moreover, if the digit is injured, the present invention can provide pain relief from the injury as well. Further, the invention can be applied to the digit in combination with other pain-reducing therapies, such as the application of ice, the application of topical analgesics, the application of local anesthetics, etc. The controller includes an on/off control switch and a switch for controlling the vibratory frequency.

Abstract: An apparatus and method for preparing a pharmaceutical for transient application includes a tray having a sealed compartment, a vial of an ophthalmic formulation of mitomycin-C, a diluent carrier containing sterilized water, and a syringe that are all contained together in a single package. The component parts of the apparatus are used together to reconstitute the contents of the vial with the water in the diluent carrier, and then draw the reconstituted drug into the sealed compartment of the tray by a suction force produced by the syringe. In the tray compartment, the reconstituted drug is absorbed in at least one absorbent pad. The absorbent pads may come in multiple shapes and or/sizes. The tray is opened to remove the pad and the absorbed drug from the tray compartment for use of the pad in transient application of the drug.

Abstract: A system, method and apparatus for real time measurement and monitoring of various personal health parameters including controlled delivery of drugs/medications by intelligent pump appliances, intelligent inhalation appliances and intelligent skin patch appliances used in a standalone manner or in a wired or wireless networked configuration, in conjunction with various peripheral devices, other intelligent appliances, servers, RF ID Tags and stationary/mobile devices. The intelligent appliances relate to the measurement, monitoring and delivery of insulin/other drugs for the treatment of diabetes and other diseases. The method also additionally includes the application of intelligent appliances for pain management including visualization of organs and body locations exhibiting pain.

Abstract: A rechargeable type callus removal instrument is disclosed, that includes a main body having a flaring tube shape with one side opened. The instrument can include a callus storage fitted around the motor shaft of an internal motor that rotates with rotation of the motor shaft, thereby collecting calluses separated from a user's foot therein. A filing cap can cover an upper surface of the callus storage for removing calluses on the user's foot while rotating with the callus storage in contact with a callus surface of the foot. A guide member can be included to assist with forming an exterior barrier such that the calluses being removed by the filing cap are collected in the callus storage without scattering about to the outside. The callus removal instrument enables callus removal using a rotational force of a motor through electric recharging with an improved portability while preventing water infiltration.

Abstract: A treatment device and associated methods are disclosed, the treatment device comprising: a fluid dispenser comprising: a sealable reservoir for storing a fluid to be dispensed; a transfer body for carrying a predetermined volume of said fluid from said reservoir to a dispensing point outside of said reservoir; and a sliding seal for maintaining said reservoir in a sealed state while a portion of said transfer body carrying said predetermined volume of fluid and said predetermined volume of fluid are moved from a position inside of said reservoir to said dispensing point outside of said reservoir; and an applicator for applying a predetermined volume of fluid present at said dispensing point to a part of the human or animal body, wherein said applicator comprises means for dispersing said predetermined volume of fluid in a jet of gas directed towards said part of the human or animal body.

Abstract: The invention provides a polymeric medical sealant. The medical sealant is useful for application to the tonsils and adenoids, wherein the sealant performs at least one of the following functions, a) inhibit the colonization of bacteria, b) inhibit the binding of bacteria to tissue, c) reduction of tissue morbidity, d) hemostasis, e) coating and protection of tissue during healing. f) promotion of healing, and g) reduction of pain.

Abstract: A disinfectant delivery system and method of providing alcohol-free disinfection to a body to be disinfected, as well as a method of infection reduction by preparation of a patient before an invasive procedure. A blended cloth comprising first fibers and second fibers is provided with the first fibers generally being greater in quantity by weight than the second fibers. A disinfectant solution impregnates the blended cloth, with the disinfectant solution having chlorhexidine gluconate as an active ingredient and having no alcohol. In the method according to the invention, at least one impregnated blended cloth is used to disinfect at least a portion of a body. A plurality of blended cloths can be provided for disinfecting discrete portions of the body.

Abstract: A device for applying an ophthalmologic medicament to a patient's eye is disclosed. The device comprises spectacles defined by a frame and at least one lens; at least one container adapted for accommodating the ophthalmologic medicament; the container is incorporated into the frame; dosing mechanism adapted to control doses of the medicament; and at least one nozzle in a fluid interconnection with the medicament container; the nozzle is secured mechanically to the frame; the nozzle is adapted for providing a medicament mist flow. The nozzle is placed in front of a peripheral portion of a patient's eye slot and adapted to provide the mist flow in front of the patient's eye.

Abstract: An architecture is presented that provides a topical cream delivery device designed for effectively and easily administering hydrating and pain-relieving creams to dialysis patients' and other “in need” patients' needle sites. The topical cream delivery device comprises an adhesive bandage strip and a cavity positioned along the adhesive bandage strip. The cavity is typically filled with a hydrating and pain-relieving cream for dialysis patients, but could be filled with any other suitable cream or drug as well. The adhesive bandage strip further comprises an adhesive backing, for adhering to a user's skin. The adhesive bandage strip is attached to the adhesive backing on one side and covered with a protective paper on the other and cut to shape for application to a body surface. A user when using the topical cream delivery device peels off the protective paper from the adhesive backing and adheres the device to a body surface.

Abstract: A wound treatment device comprises a polyurethane or polyether foam pad, adapted for insertion substantially within a wound cavity; a pump for supplying fluid flow to the wound site; and a collection canister for receiving wound fluids drawn from the wound cavity. The foam pad, pump and collection canister are in fluid communication with one another through a single hospital grade hose having a plurality of tiny apertures in the portion that is central to the foam pad. These apertures are adapted to allow fluids from the wound cavity to be drawn into the flow from the pump to the canister according to Bernoulli's theorem.

Abstract: A composition comprising an alcohol and an aloe vera gel for topically treating hot flashes and methods for the storing, dispensing and application thereof.

Abstract: The present invention is related to articles of clothing that can be used to lessen the symptoms of particular diseases and/or skin conditions, designs of the clothing, and methods and tools for commercializing and marketing the clothing. In one aspect, the present invention is directed to an article of clothing. The article of clothing includes at least a first coating. The first coating decreases the wicking or absorbance of water as compared to clothing that does not include the coating.

Abstract: A transdermal drug delivery system for the topical application of one or more active agents contained in one or more polymeric and/or adhesive carrier layers, proximate to a non-drug containing polymeric backing layer which can control the delivery rate and profile of the transdermal drug delivery system by adjusting the moisture vapor transmission rate of the polymeric backing layer.

Abstract: An apparatus configured to provide a beneficial biological effect for a subject, and/or a method of treating the subject using the apparatus. The apparatus may be configured to trigger and maintain the elevation of Glutathione levels within the subject. The apparatus may rely on a non-invasive mechanism to elevate Glutathione levels in the subject. The apparatus may not require a traditional power source such as a battery or wall plug in order to be effective in elevating Glutathione levels in the subject. To trigger and maintain the elevation of Glutathione levels within the subject, the apparatus may transmit communication to the body of the subject that results in increased levels of Glutathione within the subject.

Abstract: The present invention relates to an ocular implant, particularly a glaucoma stent. It is the object of the present invention to devise an ocular implant which allows the ocular eye pressure to be regulated, i.e., to be maintained at a desired level, while preventing the flow resistance from increasing over time, for example due to fibrosis. In order to achieve this object, the ocular implant according to the invention comprises a small tube (5), the wall surface (3) of which encloses a hollow duct that is open on both sides in the longitudinal direction of the hollow duct, wherein a first opening (1) allowing ocular humor to flow in and a second opening (2) allowing the ocular humor to be discharged is provided, and wherein the wall surface (3) is formed by a liquid-tight material, and wherein at least one pressure-controlled valve (4) is disposed in the area of the wall surface (3).

Abstract: The present invention provides a device to facilitate the self-administration of eye drops. The device includes a body portion adapted for placement on the user's face, generally over the eye in which the drops are to be applied. The body portion preferably includes an integral handle which may be held between the thumb and forefinger of the user. Many embodiments may also incorporate a nose bridge to assist in locating the device in the correct position.

Abstract: A phototherapy apparatus is disclosed including: a handpiece including a body member and a grip; a plurality of elongated light transmitting elements, each of the elements extending between a proximal end enclosed within the body member and a distal end located outside of and distal to the body member; an ultraviolet light source; a light collection element; and one or more optical coupling elements. The proximal ends of the light transmitting elements are located in close proximity to each other The light collection element is configured to collect at least a portion of the light emitted from the light source. The one or more optical coupling elements are configured to direct at least a portion of the collected light to the proximal ends of the light transmitting elements to couple at least portion of the collected light into the light transmitting elements The light coupled into each of the light transmitting elements is transmitted along the element and emitted from the distal end.

Abstract: The invention relates to transdermal therapeutic systems (TTS) comprising a backing, a reservoir layer containing at least one pharmaceutical active ingredient, and an adhesive. Said transdermal therapeutic systems are characterised in that they are able to continuously adhere to the surface of the skin over a long period of time. During said long period of time, a) there is at least one time interval during which the TTS adhering to the surface of the skin is intensively exposed to water, and b) the active ingredient is transdermally released. The invention also relates to a method for the continuous transdermal release of at least one pharmaceutical active ingredient over a long period of time.

Abstract: Methods and systems for treating a wound using targeted delivery of magnetically-tagged active agents in combination with negative pressure wound therapy are presented. In particular, a magnetically-active wound insert may be used to attract magnetically-tagged stem cells to a wound site to treat the wound.

Abstract: An attachment for use with a unit dose eye drop dispenser comprises a tapered receptacle and a lateral positioning arm. The tapered receptacle is “squeezable” so that a reservoir of the unit dose dispenser can be placed within the receptacle and the walls of the receptacle squeezed to dispense a droplet. The positioning arm is shaped to be placed over the patient's nosebridge to properly position the receptacle over the eye for optimum placement of an eye drop.

Abstract: A method of delivering safe, suitable, and repeatable dosages to a subject for topical, oral, nasal, or pulmonary use and a device for droplet ejection includes a fluid delivery system capable of delivering a defined volume of the fluid in the form of droplets having properties that afford adequate and repeatable high percentage deposition upon application. The method and device include a housing, a reservoir disposed within the housing for receiving a volume of fluid, an ejector mechanism configured to eject a stream of droplets having an average ejected droplet diameter greater than 15 microns, the stream of droplets having low entrained airflow such that the stream of droplets deposit on the eye of the subject during use.

Abstract: A therapeutic system comprises an ocular insert placed on a region outside an optical zone of an eye. The ocular insert comprises two structures: a first skeletal structure and a second cushioning structure. The first structure functions as a skeletal frame which maintains positioning of the implant along the anterior portion of the eye and provides support to the second, cushioning structure. This first structure maintains the attachment of the therapeutic system to the anterior portion of the eye for at least thirty days. In some embodiments the first structure remains a constant size and shape, e.g. a ring shape, a ring with haptics, or a curvilinear ring that is confined to and restrainingly engages the inferior and superior conjunctival fornices so as to retain the implant within the tear fluid and/or against the tissues of the eye.

Abstract: Provided according to some embodiments of the invention are wound dressings that include a polymer matrix and nitric oxide-releasing polysiloxane macromolecules within and/or on the polymer matrix. Also provided are wound dressing kits and methods of using and forming such wound dressings.

Abstract: An abdominal wound dressing and methods of use are described that enable the application of negative pressure to the wound site in a healing manner while also limiting the formation of adhesions that would prevent the removal of the dressing. The method comprises providing a flexible film having a plurality of holes therein and placing the flexible film in the wound. The flexible film has a first, patient-facing side and a second side. The method includes placing a porous pad on top of the second side of the flexible film. The flexible film and porous pad are sealed within the wound with a drape that is positioned in contact with an area of skin surrounding the wound. A negative pressure is provided to the porous pad for drawing a flow of exuded fluids from the wound.

Abstract: The present invention is directed to an intermittent aerosol dispensing device, for application of a product to skin of a human being, where the aerosol dispensing device includes an intermittent injection mechanism located downstream of an aerosol valve of an aerosol dispenser and responsive to a pushbutton of the aerosol dispensing device, and the aerosol dispensing device further includes a pressure chamber. A ratio of an injection time to a stop time is set, in said intermittent injection mechanism, to 0.1 to 5.0, so that when said aerosol valve is opened a cycle of injection and stop is performed 1 to 25 times per second in order to obtain a cooling and/or massage effect on the skin.

Abstract: A method for moisturizing the eye in which an amount of aqueous fluid is administered to the eye in an amount below that which causes flooding of the eye and removal of the normal tear film from the surface of the eye. The fluid, when administered in accordance with the invention, rehydrates the already present tear film rather than replacing the tear film. A kit for moisturizing the eye in accordance with the invention is also disclosed.

Abstract: A computer-controlled system determines attributes of a frexel, which is an area of human skin, and applies a reflectance modifying agent (RMA) at the pixel level to automatically change the appearance of human features based on one or more digital images. The change may be based on a digital image of the same frexel, for as seen in a prior digital photograph captured previously by the computer-controlled system. The system scans the frexel and uses feature recognition software to compare the person's current features in the frexel with that person's features in the digital image. It then calculates enhancements to the make the current features appear more like the features in the digital image, and it applies the RMA to the frexel to accomplish the enhancements. Or the change may be based on a digital image of another person, through the application of RMAs.

Abstract: An in situ forming foam for medical applications and a method for making same is described, the method comprising the steps of: preparing a first component, Composition A, comprising an acidic solution of a polycationic polymer selected from the group comprising polymeric amines and polysaccharides; preparing a second component, Composition B, selected from the group comprising a metal carbonate, a metal bicarbonate or a mixture of a metal carbonate and a metal bicarbonate; maintaining said first and second components separately prior to mixing; and mixing said first and second components at an intended site of application. The foam is a mechanically robust but flexible and resilient material wherein the degree and nature of the porosity may be controlled.

Abstract: Methods, apparatuses and systems are disclosed for conditioning a foot surface by contacting a foot surface with an article designed to contact foot surfaces for the purpose of abrading, moisturizing and otherwise conditioning a foot surface.

Abstract: Embodiments of the invention are directed to methods of treating a wound by administering a wound-healing composition and the wound-healing composition. The wound-healing composition has a purified platelet-removed platelet-rich plasma and a wound-healing component. The wound-healing component is a protein, a peptide, or combinations thereof. The methods of treatment utilize an amount of the wound-healing composition sufficient to treat a patient with a wound, which may occur by promoting an activity of cell migration, cell proliferation, and/or angiogenesis. Also disclosed are processes for preparing the wound-healing composition.

Abstract: This patent application teaches methods and apparatus of an efficient disposal chain system which includes a process of receiving fluid enclosing containers, transforming said containers into collection containers by integrating said containers into vacuum canister collection systems. Such a collection system includes a remote vacuum source configured to draw a vacuum force away from said container and towards said container. Such a vacuum source is configured to draw room air. Such a force is configured to draw waste materials along a path towards said collection container. A transformation of said containers includes deriving said containers from supply chains and transforming said containers into said collection systems at least in part by supporting said containers inside said canisters from below utilizing various configurations of measurement stands, said stands configured to support and accommodate various sizes, types and shapes of said containers.

Abstract: A multi-layer reduced pressure delivery apparatus is provided for applying reduced pressure tissue treatment to a tissue site. The multi-layer apparatus includes a tissue contact layer, a release layer, and a manifold layer. The tissue contact layer includes a scaffold adapted to contact the tissue site, the release layer includes a water-soluble polymer and a plurality of flow channels, and the manifold layer includes a distribution manifold. The release layer is positioned between the tissue contact layer and the manifold layer to allow easy release of the manifold layer from the tissue contact layer following the administration of reduced pressure tissue treatment.

Abstract: A method of bridging from a wound dressing to a wound port for negative pressure wound therapy includes positioning an elongate wick between a wound and a remote location with respect to the wound. The elongate wick includes a three-dimensional spacer fabric having an upper fabric layer spaced from a lower fabric layer by an intermediate layer of pile threads. The elongate wick is covered with a flexible wick cover such that an enclosure is formed around the elongate wick. A substantially fluid-tight seal is established between a first end of the elongate wick cover and the wound dressing such that a reservoir is defined over the wound in which a negative pressure may be maintained. A substantially fluid-tight seal is established between a second end of the elongate wick cover and a fluid port configured for connection to a source of negative pressure.

Abstract: A method and apparatus for thawing and delivery of cryogenically frozen biological material, such as stem cells includes a housing for receiving a pouch of frozen cells, a heating element against which the pouch is placed for applying defrosting heat to the pouch, and a squeezing apparatus for applying a squeezing force to the pouch after or upon thawing of the cells. The squeezing force may be applied by a roller pressing the pouch against the heating element, which forces the thawed cells from a needle or tube connected to the housing and/or to the pouch. A rechargeable battery in the housing supplies power to the heating element and the squeezing apparatus.

Abstract: The present invention discloses a medical device having a disposable member for treating dermatological diseases and topical pathogeneses. The device comprises, inter alia, at least one inner layer at least partially made of a non-woven material, being in physical contact with at least a part of the derma having the dermatological diseases; at least one external impervious and flexible layer, at least partially made of material selected from a group consisting of silicone, rubber and polymer, enveloping the inner layer; and, source of hypertonic solution wetting the inner layer such that the inner layer is continuously immersed with the hypertonic solution and a constantly hypertonic environment around the derma is maintained. The inner layer is disposable and reversibly detachable to the enveloping external layer such that frequent displacement of the inner layer is possible, topical pathogeneses are being removed and dermatological diseases are being treated.

Abstract: An antiviral transdermal patch including a backing layer, a viscous polymer layer, and a protection film layer. The viscous polymer layer includes an antiviral agent, a viscous polymer, and a transdermal enhancer. The transdermal enhancer is laurocapram or a mixture thereof. The antiviral agent is a nucleoside antiviral drug with a daily delivery rate of less than 100 mg/day. The patch effectively promotes the penetration of a nucleoside antiviral agent into the blood circulation and avoids enzymolysis in the gastrointestinal tract and the first pass effect of the liver and reduces side effect of drugs, thereby inhibiting the replication of target viruses and reducing viral DNA level in the serum. A method for producing the patch is also provided. The raw materials involved in the invention are easily purchased from the market at a low cost.